Barbero Umberto, Fornari Federico, Guarguagli Silvia, Gaglioti Carmen Maria, Longo Filomena, Doronzo Baldassarre, Anselmino Matteo, Piga Antonio
a Royal Brompton and Harefield Hospital , Imperial College London , London , UK.
b Cardiology Unit , SS. ma Annunziata Hospital , Savigliano , Italy.
Hemoglobin. 2018 May;42(3):189-193. doi: 10.1080/03630269.2018.1488724. Epub 2018 Oct 1.
The prevalence of atrial fibrillation (AFib) in β-thalassemia major (β-TM) patients has increased in the last few years, reaching up to 33.0%. Several factors may drive this value to even more in the next few years. We summarized the main challenges in the management and therapy of AFib in this very specific group of patients.
近年来,重型β地中海贫血(β-TM)患者中房颤(AFib)的患病率有所上升,高达33.0%。未来几年,多种因素可能会使这一数值进一步升高。我们总结了这一特殊患者群体房颤管理和治疗中的主要挑战。